Related Experiment Video

Updated: Mar 16, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.9K

MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene

Youguang Pu1, Qiyi Yi2, Fangfang Zhao1

  • 1Cancer Epigenetics Program, Anhui Cancer Hospital, West District of Affiliated Provincial Hospital of Anhui Medical University, Hefei, 230031 Anhui China.

Cancer Cell International
|August 9, 2016
PubMed
Abstract

Insights

MicroRNA-20a-5p (miR-20a-5p) can overcome chemoresistance in osteosarcoma by targeting KIF26B. This finding is crucial for improving treatment strategies and patient survival rates in osteosarcoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Chemoresistance significantly limits curative chemotherapy for osteosarcoma (OS).
  • Metastatic OS at diagnosis is associated with a poor survival rate of approximately 20%.
  • Understanding chemoresistance mechanisms is vital for enhancing OS treatment outcomes.

Purpose of the Study:

  • To investigate the role of miR-20a-5p in osteosarcoma chemoresistance.
  • To identify the molecular targets and signaling pathways regulated by miR-20a-5p in OS.
  • To explore the therapeutic potential of targeting miR-20a-5p for overcoming chemoresistance.

Main Methods:

  • Quantitative real-time PCR to measure miR-20a-5p and KIF26B mRNA expression.
  • Western blot analysis to determine KIF26B protein levels.
  • MTT assays for cell viability and flow cytometry for apoptosis evaluation in OS cell lines and xenografts.

Main Results:

  • miR-20a-5p expression was lower in chemoresistant OS cells (SJSA-1) compared to chemosensitive cells (G-292).
  • Upregulation of miR-20a-5p reduced OS cell chemoresistance in vitro and in vivo.
  • Kinesin family member 26B (KIF26B) was identified as a target of miR-20a-5p, mediating its effect on chemoresistance via MAPK/ERK and cAMP/PKA pathways.

Conclusions:

  • miR-20a-5p and KIF26B play significant roles in regulating osteosarcoma chemoresistance.
  • Targeting miR-20a-5p may represent a novel strategy to overcome chemoresistance in OS.
  • These findings offer critical insights for predicting drug responsiveness and improving treatment for OS patients.
Keywords:
KIF26BMulti-drug resistanceOsteosarcomamiR-20a-5p

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.9K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K